GO:0055090 acylglycerol homeostasis: Lipid Droplet Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055090 acylglycerol homeostasis is the biological process that maintains steady-state levels of acylglycerols (mono-, di-, and triacylglycerols) within cells and organisms.
• Triacylglycerol (TAG) and diacylglycerol (DAG) are the major acylglycerol species; their homeostasis is central to energy storage, membrane biogenesis, and signaling.
• Key regulators include lipases (PNPLA2/ATGL, LIPE/HSL), lipid droplet proteins (PLIN1-5), and seipin (BSCL2), which govern lipid droplet formation and turnover.
• Disruption of acylglycerol homeostasis contributes to metabolic diseases such as hepatic steatosis, obesity, insulin resistance, and lipodystrophy.
• Yeast models (Saccharomyces cerevisiae) have provided foundational insights into TAG homeostasis and lipid droplet biology.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of genes involved in acylglycerol homeostasis.
Description
Acylglycerol homeostasis (GO:0055090) refers to any process involved in the maintenance of an internal steady state of acylglycerol within an organism or cell. Acylglycerols are esters of glycerol and fatty acids, encompassing monoacylglycerols (MAGs), diacylglycerols (DAGs), and triacylglycerols (TAGs). Among these, TAG is the primary form of stored energy in most organisms, while DAG serves as a key intermediate in lipid synthesis and a signaling molecule. The regulation of acylglycerol levels is essential for cellular energy balance, membrane lipid synthesis, and the prevention of lipotoxicity. Research into acylglycerol homeostasis has revealed a complex interplay between lipid synthesis, storage in lipid droplets, and lipolytic breakdown. In yeast, triacylglycerol homeostasis is tightly linked to lipid droplet dynamics and cell cycle progression. In mammals, the liver is a central organ for acylglycerol metabolism, where insulin and nutrient status regulate the balance between TAG synthesis and secretion. Dysregulation of this process is a hallmark of common metabolic disorders, including non-alcoholic fatty liver disease (NAFLD), obesity, and type 2 diabetes. Understanding the molecular players and regulatory mechanisms of acylglycerol homeostasis is therefore critical for developing therapeutic strategies. Recent studies have identified novel regulators such as lipopolysaccharide binding protein (LBP) in hepatic oxidative stress, ORP8 as a lipophagy receptor, and seipin in phosphatidic acid homeostasis. These findings underscore the importance of precise experimental models to dissect gene function in this pathway.
acylglycerol homeostasis At A Glance
| GO ID | GO:0055090 |
|---|---|
| GO term | acylglycerol homeostasis |
| Ontology | biological_process |
| Synonym | glyceride homeostasis |
| Major function | Maintenance of steady-state levels of mono-, di-, and triacylglycerols within cells and organisms |
| Key organelles | Lipid droplets, endoplasmic reticulum, mitochondria |
| Major lipid species | Triacylglycerol (TAG), diacylglycerol (DAG), monoacylglycerol (MAG) |
| Related processes | Lipid droplet biogenesis, lipolysis, lipophagy, fatty acid esterification |
| Disease relevance | Hepatic steatosis, obesity, insulin resistance, lipodystrophy, metabolic syndrome |
What Is GO:0055090?
Acylglycerol homeostasis (GO:0055090) is defined as any process involved in the maintenance of an internal steady state of acylglycerol within an organism or cell. This includes the regulation of synthesis, storage, mobilization, and degradation of acylglycerol species such as mono-, di-, and triacylglycerols. The term is synonymous with glyceride homeostasis and is a biological process ontology term.
Why Is acylglycerol homeostasis Important in Cell Biology?
Acylglycerol homeostasis is fundamental to energy metabolism and cellular health. Triacylglycerols serve as the primary energy reserve in adipose tissue and other organs, while diacylglycerols act as second messengers and intermediates in phospholipid synthesis. The maintenance of appropriate acylglycerol levels prevents lipotoxicity, a condition where excess lipids cause cellular stress and dysfunction. In the liver, insulin tightly regulates lipid homeostasis, and its dysregulation leads to steatosis and insulin resistance. In yeast, triacylglycerol homeostasis is essential for survival during stationary phase and for lipid droplet inheritance. Consequently, understanding the mechanisms that govern acylglycerol homeostasis is crucial for addressing metabolic diseases and for basic cell biology.
• Maintains energy balance by storing excess fatty acids as inert triacylglycerols in lipid droplets.
• Prevents lipotoxicity by sequestering free fatty acids and diacylglycerols that can disrupt membrane integrity and signaling.
• Supports membrane biogenesis by providing diacylglycerol for phospholipid synthesis.
• Regulates lipid droplet dynamics, including biogenesis, growth, and turnover via lipophagy.
• Is critical for hepatic lipid homeostasis and insulin sensitivity.
• Dysregulation is linked to obesity, fatty liver disease, and lipodystrophy.
• Yeast models have elucidated conserved pathways of triacylglycerol homeostasis.
• Fungal diacylglycerol metabolism impacts physiology and virulence.
• Seipin mutations cause lipodystrophy and disrupt phosphatidic acid homeostasis at the nuclear membrane.
• LBP resists hepatic oxidative stress by regulating lipid droplet homeostasis.
What Happens During acylglycerol homeostasis?
Triacylglycerol Synthesis and Storage
In simple terms: Cells make triacylglycerols from fatty acids and glycerol and store them in lipid droplets.
Triacylglycerol (TAG) synthesis occurs primarily in the endoplasmic reticulum (ER), where diacylglycerol acyltransferases (DGATs) catalyze the final step of esterifying diacylglycerol with acyl-CoA. In yeast, TAG homeostasis is tightly linked to lipid droplet formation and cell cycle progression. The synthesized TAG is packaged into lipid droplets, which are dynamic organelles that store neutral lipids. The yeast model has been instrumental in identifying genes such as DGA1, LRO1, ARE1, and ARE2 that contribute to TAG synthesis and homeostasis. In mammals, hepatic TAG synthesis is regulated by insulin and nutrient availability, and excess TAG accumulation leads to steatosis.
Lipid Droplet Dynamics and Lipophagy
In simple terms: Lipid droplets can be broken down by autophagy to release fatty acids.
Lipid droplets are not static storage depots; they undergo regulated turnover. ORP8 acts as a lipophagy receptor that mediates lipid droplet turnover by targeting them for autophagic degradation. This process, termed lipophagy, is crucial for mobilizing stored TAG when energy is needed. In yeast, lipid droplet inheritance and degradation are coordinated with the cell cycle, ensuring proper distribution of lipids to daughter cells. The interplay between lipid droplet biogenesis and lipophagy maintains acylglycerol homeostasis.
Lipolysis and Fatty Acid Release
In simple terms: Enzymes called lipases break down triacylglycerols into free fatty acids and glycerol.
Lipolysis is the enzymatic breakdown of TAG into free fatty acids and glycerol. Key lipases include adipose triglyceride lipase (PNPLA2/ATGL) and hormone-sensitive lipase (LIPE/HSL). In the liver, insulin suppresses lipolysis and promotes TAG storage, while during fasting, lipolysis is activated to provide energy substrates. In yeast, TAG lipases such as Tgl3, Tgl4, and Tgl5 are involved in TAG mobilization. Dysregulation of lipolysis contributes to elevated circulating fatty acids and ectopic lipid accumulation.
Regulation by Seipin and Phosphatidic Acid
In simple terms: Seipin controls the levels of phosphatidic acid, a lipid that affects lipid droplet formation.
Seipin (BSCL2) is an ER membrane protein that governs phosphatidic acid homeostasis at the inner nuclear membrane. Mutations in seipin cause congenital generalized lipodystrophy, highlighting its role in acylglycerol homeostasis. Seipin deficiency leads to abnormal lipid droplet morphology and impaired TAG storage. This regulation is critical for maintaining the balance between phospholipid and neutral lipid synthesis.
Impact of Oxidative Stress and LBP
In simple terms: A protein called LBP helps protect the liver from oxidative stress by managing lipid droplets.
Lipopolysaccharide binding protein (LBP) resists hepatic oxidative stress by regulating lipid droplet homeostasis. LBP deficiency exacerbates oxidative stress and lipid accumulation in the liver, indicating its protective role in acylglycerol homeostasis. This links inflammatory signaling to lipid metabolism and suggests that LBP may be a therapeutic target for steatotic liver diseases.
Key Genes Involved in GO:0055090 acylglycerol homeostasis
The following genes and proteins are central to acylglycerol homeostasis, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PNPLA2 (ATGL) | Adipose triglyceride lipase; catalyzes first step of TAG hydrolysis | Key regulator of lipolysis; knockout causes steatosis |
| LIPE (HSL) | Hormone-sensitive lipase; hydrolyzes DAG and TAG | Critical for mobilization of stored fat |
| DGAT1/2 | Diacylglycerol acyltransferases; final step of TAG synthesis | Targets for reducing hepatic steatosis |
| PLIN1-5 | Perilipins; coat lipid droplets and regulate lipolysis | Modulate access of lipases to lipid droplets |
| BSCL2 (Seipin) | ER protein governing phosphatidic acid homeostasis and lipid droplet formation | Mutations cause lipodystrophy |
| ORP8 (OSBPL8) | Lipophagy receptor mediating lipid droplet turnover | Regulates autophagic degradation of lipid droplets |
| LBP | Lipopolysaccharide binding protein; regulates lipid droplet homeostasis under oxidative stress | Protective role in hepatic steatosis |
| BMAL1 | Core circadian clock gene; deficiency prevents high-fat diet-induced obesity | Links circadian rhythm to lipid metabolism |
| DGA1 | Yeast diacylglycerol acyltransferase; TAG synthesis | Model for TAG homeostasis |
| LRO1 | Yeast phospholipid:diacylglycerol acyltransferase; TAG synthesis | Alternative TAG synthesis pathway |
| ARE1/ARE2 | Yeast acyl-CoA:sterol acyltransferases; contribute to TAG homeostasis | Sterol and TAG esterification |
| TGL3/TGL4/TGL5 | Yeast TAG lipases | Mobilization of stored TAG |
| MGL2 | Yeast monoacylglycerol lipase | DAG and MAG metabolism |
| DGA1 (fungal) | Diacylglycerol acyltransferase in fungi | DAG homeostasis in fungal physiology |
| PKC1 | Protein kinase C; regulated by DAG in yeast | DAG signaling in cell wall integrity |
| HNF4A | Hepatocyte nuclear factor 4 alpha; regulates lipid metabolism genes | Linked to hepatic lipid homeostasis |
| INSR | Insulin receptor; mediates insulin regulation of hepatic lipid homeostasis | Insulin signaling in lipid metabolism |
| SREBF1 | Sterol regulatory element-binding transcription factor 1; promotes lipogenesis | Transcriptional control of TAG synthesis |
How Is acylglycerol homeostasis Regulated?
Acylglycerol homeostasis is regulated at multiple levels, including transcriptional, post-transcriptional, and post-translational mechanisms. Insulin signaling plays a central role in hepatic lipid homeostasis by promoting lipogenesis and suppressing lipolysis. The circadian clock gene Bmal1 regulates intestinal lipid absorption and metabolism; its deficiency prevents high-fat diet-induced obesity. In yeast, TAG homeostasis is coordinated with the cell cycle, ensuring proper lipid droplet inheritance. Additionally, seipin regulates phosphatidic acid levels at the inner nuclear membrane, influencing lipid droplet formation. Oxidative stress and inflammatory signals, such as LBP, also modulate lipid droplet homeostasis. These regulatory layers ensure that acylglycerol levels are adapted to nutrient availability and cellular demands.
acylglycerol homeostasis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BSCL2 (Seipin) | Congenital generalized lipodystrophy | Knockout mouse, patient-derived iPSCs |
| LBP | Hepatic oxidative stress and steatosis | Liver-specific knockout mouse |
| ORP8 (OSBPL8) | Lipid droplet turnover and NAFLD | Knockout hepatocytes, overexpression models |
| BMAL1 | Obesity and circadian lipid metabolism | Intestinal-specific knockout mouse |
| PNPLA2 (ATGL) | Neutral lipid storage disease | Knockout mouse, cell models |
Hepatic Steatosis and Non-Alcoholic Fatty Liver Disease (NAFLD)
Dysregulation of acylglycerol homeostasis leads to excessive hepatic TAG accumulation, a hallmark of NAFLD. Insulin resistance promotes lipolysis and hepatic de novo lipogenesis, contributing to steatosis. LBP deficiency exacerbates oxidative stress and lipid accumulation in the liver, suggesting a protective role for LBP in NAFLD. ORP8-mediated lipophagy is also important for preventing lipid droplet accumulation. Therefore, genes involved in TAG synthesis, lipolysis, and lipophagy are potential therapeutic targets for NAFLD.
Obesity and Insulin Resistance
Obesity is characterized by excessive adipose tissue expansion and ectopic lipid deposition. Deficiency of intestinal Bmal1 prevents high-fat diet-induced obesity, highlighting the role of circadian rhythms in acylglycerol homeostasis. Insulin resistance is both a cause and consequence of impaired acylglycerol homeostasis, as excess DAG and TAG interfere with insulin signaling. Targeting pathways that restore acylglycerol balance may improve insulin sensitivity.
Lipodystrophy and Seipinopathies
Mutations in BSCL2 (seipin) cause congenital generalized lipodystrophy, a severe disorder characterized by near-total absence of adipose tissue and ectopic lipid accumulation. Seipin governs phosphatidic acid homeostasis at the inner nuclear membrane, and its loss disrupts lipid droplet formation. This demonstrates the critical role of seipin in acylglycerol homeostasis and human disease.
Fungal Pathogenesis and DAG Signaling
In fungi, diacylglycerol metabolism and homeostasis are essential for physiology and virulence. DAG acts as a second messenger in the PKC1 cell wall integrity pathway, and its misregulation affects fungal growth and stress responses. Understanding acylglycerol homeostasis in fungi may inform antifungal drug development.
From acylglycerol homeostasis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate hepatic TAG levels? | Liver-specific knockout mouse or CRISPR KO in HepG2 cells |
| Does a point mutation in gene Y affect lipolysis? | CRISPR point-mutation knock-in in adipocytes |
| Does overexpression of gene Z reduce steatosis? | AAV-mediated overexpression in mouse liver |
| Does gene W localize to lipid droplets? | Tagged knock-in (e.g., GFP) in cell lines |
| Is gene V required for lipophagy? | CRISPR knockout in HeLa or HepG2 cells followed by lipophagy assays |
| Does gene U affect DAG signaling in fungi? | CRISPR knockout in Candida albicans or Saccharomyces cerevisiae |
How to Study the acylglycerol homeostasis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS/MS) | Quantification of TAG, DAG, MAG species | Assessing acylglycerol levels in cells or tissues |
| BODIPY 493/503 staining | Lipid droplet number, size, and intensity | High-content screening for lipid droplet regulators |
| Oil Red O staining | Neutral lipid content | Histological assessment of steatosis |
| CRISPR knockout screening | Gene essentiality for acylglycerol homeostasis | Discovery of novel regulators |
| RNA-seq | Transcriptional changes in lipid metabolism genes | Evaluating insulin or nutrient effects |
| Proteomics | Protein abundance and interactions | Identifying lipid droplet-associated proteins |
| Lipophagy flux assay | Autophagic degradation of lipid droplets | Studying ORP8 and other lipophagy receptors |
| Triglyceride assay kit | Colorimetric or fluorometric TAG quantification | Rapid screening of genetic variants |
Lipidomics and Mass Spectrometry
Lipidomics using mass spectrometry allows comprehensive quantification of acylglycerol species, including TAG, DAG, and MAG. This method is essential for assessing changes in acylglycerol homeostasis in response to genetic perturbations or drug treatments. Targeted lipidomics can measure specific lipid species and their acyl chain composition.
Fluorescence Microscopy and Lipid Droplet Imaging
Imaging lipid droplets with neutral lipid dyes (e.g., BODIPY 493/503, Oil Red O) enables visualization of lipid droplet number, size, and distribution. This is critical for studying genes involved in lipid droplet biogenesis and turnover, such as ORP8 and seipin. Live-cell imaging can track lipid droplet dynamics over time.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify novel regulators of acylglycerol homeostasis. For example, screens using lipid droplet staining as a readout have uncovered genes affecting TAG storage and lipolysis. These screens are powerful for discovering new therapeutic targets.
Transcriptomics and Proteomics
RNA-seq and proteomics can reveal changes in gene expression and protein abundance associated with acylglycerol homeostasis. For instance, insulin regulation of hepatic lipid homeostasis involves transcriptional changes in lipogenic and lipolytic genes. Proteomic analysis of lipid droplet-associated proteins can identify new regulators.
How CRISPR Can Be Used to Study GO:0055090 acylglycerol homeostasis
Knockout
CRISPR knockout (KO) is used to completely ablate genes involved in acylglycerol homeostasis, such as PNPLA2, BSCL2, or ORP8, to assess their causal role in lipid metabolism. KO models can be generated in cell lines (e.g., HepG2, HeLa) or in mice (e.g., liver-specific KO). These models help determine whether a gene is required for maintaining TAG levels and lipid droplet dynamics.
Point Mutation
CRISPR point mutation (e.g., via base editing or HDR) allows the introduction of specific disease-associated mutations, such as those found in BSCL2 in lipodystrophy patients. This enables precise modeling of human genetic variants and their impact on acylglycerol homeostasis without confounding effects of complete gene loss.
Knock-in
Knock-in of tagged versions of genes (e.g., GFP, FLAG) facilitates localization and interaction studies. For example, tagging seipin or ORP8 can reveal their dynamic localization to lipid droplets and ER membranes. Knock-in of reporter genes can also be used to monitor transcriptional activity of lipid metabolism genes.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression is used to increase gene dosage of candidates like LBP or Bmal1 to test their protective effects against steatosis or obesity. Overexpression models can validate gain-of-function hypotheses and identify therapeutic targets.
How EDITGENE Supports acylglycerol homeostasis Research
Researchers studying acylglycerol homeostasis-related genes often need to determine whether a candidate gene is causally involved in lipid metabolism, and to dissect the precise molecular mechanisms. This requires robust, reproducible, and scalable gene-editing models. EDITGENE provides a comprehensive suite of CRISPR services tailored to acylglycerol homeostasis research, from single-gene knockout to genome-wide library screening.
Contact EDITGENE today to design your custom CRISPR model for acylglycerol homeostasis research.
Frequently Asked Questions About acylglycerol homeostasis
What is acylglycerol homeostasis?
Acylglycerol homeostasis (GO:0055090) is the biological process that maintains steady-state levels of acylglycerols, including mono-, di-, and triacylglycerols, within cells and organisms.
What genes are involved in acylglycerol homeostasis?
Key genes include PNPLA2 (ATGL), LIPE (HSL), DGAT1/2, PLIN1-5, BSCL2 (seipin), ORP8, LBP, and BMAL1, among others.
How is acylglycerol homeostasis regulated?
It is regulated by insulin signaling, circadian clock genes like Bmal1, and lipid droplet-associated proteins such as seipin and ORP8.
What diseases are associated with acylglycerol homeostasis?
Dysregulation is linked to hepatic steatosis, NAFLD, obesity, insulin resistance, and lipodystrophy.
What is the role of seipin in acylglycerol homeostasis?
Seipin (BSCL2) governs phosphatidic acid homeostasis at the inner nuclear membrane and is essential for lipid droplet formation; mutations cause lipodystrophy.
How does ORP8 regulate lipid droplets?
ORP8 acts as a lipophagy receptor that mediates the autophagic degradation of lipid droplets, thereby controlling acylglycerol turnover.
What is the role of LBP in lipid metabolism?
LBP resists hepatic oxidative stress by regulating lipid droplet homeostasis, and its deficiency exacerbates lipid accumulation.
Can CRISPR be used to study acylglycerol homeostasis?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect gene function in acylglycerol homeostasis.
What model organisms are used to study acylglycerol homeostasis?
Saccharomyces cerevisiae is a powerful model for TAG homeostasis, while mice and cell lines are used for mammalian studies.
What methods measure acylglycerol levels?
Lipidomics by mass spectrometry, BODIPY staining, and triglyceride assays are commonly used to quantify acylglycerols.
Conclusion
Acylglycerol homeostasis (GO:0055090) is a fundamental biological process that maintains cellular lipid balance and energy storage. Its dysregulation underlies prevalent metabolic diseases, including fatty liver disease, obesity, and lipodystrophy. Research using yeast, mouse, and cell models has identified key regulators such as seipin, ORP8, LBP, and Bmal1, revealing complex regulatory networks. Continued investigation with advanced CRISPR tools will further elucidate these mechanisms and facilitate the development of targeted therapies.
References
- 1. Zhang Q et al.. 2024. Lipopolysaccharide binding protein resists hepatic oxidative stress by regulating lipid droplet homeostasis.. Nat Commun 15(1):3213 PMID: 38615060
- 2. Yu F et al.. 2021. Deficiency of intestinal Bmal1 prevents obesity induced by high-fat feeding.. Nat Commun 12(1):5323 PMID: 34493722
- 3. Pu M et al.. 2023. ORP8 acts as a lipophagy receptor to mediate lipid droplet turnover.. Protein Cell 14(9):653-667 PMID: 37707322
- 4. Romanauska A et al.. 2024. Seipin governs phosphatidic acid homeostasis at the inner nuclear membrane.. Nat Commun 15(1):10486 PMID: 39622802
- 5. Uehara K et al.. 2023. Insulin Regulation of Hepatic Lipid Homeostasis.. Compr Physiol 13(3):4785-4809 PMID: 37358513
- 7. Mondal S et al.. 2024. Diacylglycerol metabolism and homeostasis in fungal physiology.. FEMS Yeast Res 24 PMID: 39611318
- 8. Kohlwein SD. 2010. Triacylglycerol homeostasis: insights from yeast.. J Biol Chem 285(21):15663-7 PMID: 20231294
